Announcement from Shandong Wohua Pharmaceutical: The company achieved revenue of 0.395 billion in the first half of 2024, a decrease of 19.73% year-on-year. Net income attributable to shareholders of the listed company was 11.0815 million yuan, a decrease of 70.21% year-on-year. Basic earnings per share was 0.02 yuan, a decrease of 66.67% year-on-year.
沃华医药：2024年上半年净利润同比减少70.21%
Shandong Wohua Pharmaceutical: Net income decreased by 70.21% year-on-year in the first half of 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated